CompletedPhase 4NCT01579448
Evaluation of a Boosting Regimen With Oral Cholera Vaccine
Studying Cholera
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Sachin Desai
- Principal Investigator
- Suman Kanungo, MBBSNational Institute of Cholera and Enteric Diseases, India
- Intervention
- Shanchol™, oral cholera vaccine(biological)
- Enrollment
- 426 enrolled
- Eligibility
- 6 years · All sexes
- Timeline
- 2012 – 2013
Study locations (1)
- National Institute of Cholera and Enteric Diseases, Kolkata, West Bengal, India
Collaborators
National Institute of Cholera and Enteric Diseases, India · Indian Council of Medical Research
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01579448 on ClinicalTrials.govOther trials for Cholera
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2NCT07509047Age-descending Study to Evaluate the Safety and Immunogenicity of the Cholera Conjugate Vaccine in Adults and ChildrenInternational Vaccine Institute
- RECRUITINGPHASE4NCT07487077Extended Dosing Intervals Trial for Oral Cholera Vaccine, KenyaAlbert B. Sabin Vaccine Institute
- RECRUITINGPHASE3NCT07304284Trial to Evaluate Immunogenicity Non-Inferiority, Safety and Lot-to-Lot Consistency of Biovac OCV-S to Euvichol®-PlusInternational Vaccine Institute
- RECRUITINGNANCT06455852Vaccine- and Infection-derived Correlates of Protection for Cholera.Massachusetts General Hospital
- RECRUITINGNANCT06498817Testing a Scalable Model of the Cholera Hospital-Based Intervention for 7 Days (CHoBI7)Johns Hopkins Bloomberg School of Public Health
- RECRUITINGNANCT06003816Cholera-Hospital-Based-Intervention-for-7-Days (CHoBI7) Water, Sanitation, and Hygiene (WASH) Case Area Targeted Intervention (CATI)Johns Hopkins Bloomberg School of Public Health
- RECRUITINGNANCT05166850Preventative Intervention for Cholera for 7 DaysJohns Hopkins Bloomberg School of Public Health
- ACTIVE NOT RECRUITINGPHASE2NCT04326478Single Dose Azithromycin to Prevent Cholera in ChildrenMassachusetts General Hospital